This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Ticagrelor-Based Antiplatelet Regimens in Patients Treated With Coronary Artery Bypass Grafting: A Meta-Analysis of Randomized Controlled Trials

Saturday, April 11, 2020

Submitted by


Source Name: European Journal of Cardio-Thoracic Surgery


Moritz von Scheidt, Dario Bongiovanni, Ulrich Tebbe, Bernd Nowak, Jan Stritzke, Qiang Zhao, Yunpeng Zhu, Adnan Kastrati, Salvatore Cassese, Heribert Schunkert

The authors present a meta-analysis of randomized controlled trials regarding the outcome of ticagrelor-based antiplatelet therapies in patients after coronary artery bypass graft (CABG) surgery. They found a reduced rate of major adverse cardiac events and a reduced mortality in these patients receiving aspirin and/or clopidogrel. This finding should be investigated in randomized trials, as it could potentially change the standard of care of CABG patients.

Add comment

Log in or register to post comments